These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38158089)
1. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial. Goltstein LCMJ; Grooteman KV; Bernts LHP; Scheffer RCH; Laheij RJF; Gilissen LPL; Schrauwen RWM; Talstra NC; Zuur AT; Braat H; Hadithi M; Brouwer JT; Nagengast WB; Oort FA; Tenthof van Noorden J; Kievit W; van Geenen EJM; Drenth JPH Gastroenterology; 2024 Apr; 166(4):690-703. PubMed ID: 38158089 [TBL] [Abstract][Full Text] [Related]
2. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial. Grooteman KV; van Geenen EJ; Drenth JP BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668 [TBL] [Abstract][Full Text] [Related]
4. In transfusion-dependent, angiodysplasia-related anemia, adding octreotide to usual care reduced transfusions at 1 y. Flynn DJ; Feuerstein JD Ann Intern Med; 2024 Jun; 177(6):JC69. PubMed ID: 38830221 [TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647 [TBL] [Abstract][Full Text] [Related]
6. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases. Nardone G; Compare D; Scarpignato C; Rocco A Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688 [TBL] [Abstract][Full Text] [Related]
7. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias]. Boesby L; Christensen NJ; Kristensen LO Ugeskr Laeger; 2008 Mar; 170(11):958. PubMed ID: 18397628 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Orsi P; Guatti-Zuliani C; Okolicsanyi L Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511 [TBL] [Abstract][Full Text] [Related]
10. [A woman in her 60s with multifactorial anaemia]. Frigstad SO; Jønsson V; Moum B Tidsskr Nor Laegeforen; 2012 Apr; 132(8):965-8. PubMed ID: 22562330 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Nardone G; Rocco A; Balzano T; Budillon G Aliment Pharmacol Ther; 1999 Nov; 13(11):1429-36. PubMed ID: 10571598 [TBL] [Abstract][Full Text] [Related]
12. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465 [TBL] [Abstract][Full Text] [Related]
13. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Rossini FP; Arrigoni A; Pennazio M Am J Gastroenterol; 1993 Sep; 88(9):1424-7. PubMed ID: 8362842 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies. Brown C; Subramanian V; Wilcox CM; Peter S Dig Dis Sci; 2010 Aug; 55(8):2129-34. PubMed ID: 20393879 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. Olmos JA; Marcolongo M; Pogorelsky V; Herrera L; Tobal F; Dávolos JR Dis Colon Rectum; 2006 Oct; 49(10):1507-16. PubMed ID: 17024322 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. Blich M; Fruchter O; Edelstein S; Edoute Y Scand J Gastroenterol; 2003 Jul; 38(7):801-3. PubMed ID: 12889571 [TBL] [Abstract][Full Text] [Related]
17. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia. Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478 [TBL] [Abstract][Full Text] [Related]
18. Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption. Frago S; Alcedo J; Martín Pena-Galo E; Lázaro M; Ollero L; de la Llama N Scand J Gastroenterol; 2018 Dec; 53(12):1496-1502. PubMed ID: 30621520 [TBL] [Abstract][Full Text] [Related]
19. [Octreotide and angiodysplasia]. Fernández Salazar LI; de la Calle Valverde F; González Hernández JM Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743 [No Abstract] [Full Text] [Related]
20. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation. Classen CF; Haffner D; Hauenstein C; Wolf R; Kyank U BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]